Method for activating prethrombin-1
View Patent ↗Methods for converting prethrombin-1 to thrombin are disclosed. An aqueous solution of prethrombin-1 is applied to oscutarin-C immobilized on a solid support so as to provide from 500 mg to 4000 mg of prethrombin-1 per mL of the solid support and a contact time between the prethrombin-1 and the oscutarin-C of from 1.8 to 3.5 minutes. The resulting active thrombin may be captured on an ion exchange chromatography medium or an affinity chromatography medium.
1. A method for converting prethrombin-1 to thrombin comprising:
providing prethrombin-1 at a concentration of 0.1 mg/mL to 10 mg/mL in an aqueous solution of 30 mM to 110 mM NaCl at pH 6.4-8.0;
providing oscutarin-C immobilized on a solid support; and
applying the aqueous solution to the immobilized oscutarin-C so as to provide from 500 mg to 4000 mg of prethrombin-1 per mL of the solid support and a contact time between the prethrombin-1 and the oscutarin-C of from 1.8 to 3.5 minutes inclusive, whereby the prethrombin-1 is cleaved to produce thrombin, and a thrombin-containing solution is obtained.
2. The method of claim 1 further comprising:
applying the thrombin-containing solution to a capture medium selected from the group consisting of an ion exchange chromatography medium and an affinity chromatography medium, whereby the thrombin is bound to the capture medium;
washing the bound thrombin; and
recovering the bound thrombin from the capture medium.
3. The method of claim 2 wherein the capture medium is an affinity chromatography medium.
4. The method of claim 3 wherein the affinity chromatography medium comprises PABA immobilized on a solid support.
5. The method of claim 2 wherein the aqueous solution of prethrombin-1 is at pH=7.4.
6. The method of claim 2 wherein the prethrombin-1 is human prethrombin-1.
7. The method of claim 1 wherein the oscutarin-C is immobilized on a cross-linked agarose matrix.
8. The method of claim 7 wherein the concentration of oscutarin-C on the matrix is 1.0 mg/mL.
9. The method of claim 1 wherein the aqueous solution of prethrombin-1 is at pH=7.4.
10. The method of claim 1 wherein the prethrombin-1 is human prethrombin-1.
11. The method of claim 1 , which is carried out at a temperature of from 17° C. to 45° C.
12. The method of claim 11 , which is carried out at a temperature of from 20° C. to 37° C.
13. The method of claim 11 , which is carried out at a temperature of from 20° C. to 30° C.
14. The method of claim 11 , which is carried out at a temperature of 25° C.
15. The method of claim 1 wherein the oscutarin-C is immobilized on the solid support at a concentration of from 0.1 to 20 mg of oscutarin-C per mL of support.
16. The method of claim 15 wherein the concentration is from 0.1 to 5.0 mg of oscutarin-C per mL of support.
17. The method of claim 1 wherein the NaCl concentration in the aqueous solution of prethrombin-1 is 70 mM.
18. A method for converting prethrombin-1 to thrombin comprising:
providing prethrombin-1 at a concentration of 1.0 mg/mL to 10 mg/mL in an aqueous solution of 30 mM to 110 mM NaCl at pH=6.8-8.0;
providing oscutarin-C immobilized on a solid support at a concentration of from 0.1 mg to 20 mg of oscutarin-C per mL of support; applying the prethrombin-1 to the immobilized oscutarin-C so as to provide a ratio of prethrombin-1:oscutarin-C of from 500 mg to 4000 mg of prethrombin-1 per mL of the solid support and a contact time between the prethrombin-1 and the oscutarin-C of from 1.8 to 3.5 minutes at a temperature of from 20° C-30° C., whereby the prethrombin-1 is cleaved to produce thrombin, and a thrombin-containing solution is obtained;
applying the thrombin-containing solution to immobilized PABA whereby the thrombin is bound to the PABA;
washing the bound thrombin to remove impurities; and
recovering the bound thrombin from the immobilized PABA.
19. The method of claim 18 wherein the recovering step comprises washing the immobilized PABA with NaCl and isopropanol at concentrations sufficient to elute the bound thrombin.